Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

AsttraZeneca Pharmaceuticals LP recalls Airsupra (albuterol and budesonide) inhalation aerosol

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Defective delivery system
Products
  • Airsupra (albuterol and budesonide) inhalation aerosol
Company
AsttraZeneca Pharmaceuticals LP
Where it was sold

USA Nationwide

Nationwide

Units affected
a) 807,837 canisters; b) 235,698 canisters
About this recall
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .